Related references
Note: Only part of the references are listed.Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators
Yuanying Fang et al.
BIOORGANIC CHEMISTRY (2020)
Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-b][1,4]oxazine derivatives as potent GPR 119 agonists
Yuanying Fang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats
Yafang Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2020)
The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119
Gang Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Anxiety during alcohol withdrawal involves 5-HT2C receptors and M-channels in the lateral habenula
Rao Fu et al.
NEUROPHARMACOLOGY (2020)
GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats
Samantha M. Fortin et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics
Julia Ast et al.
NATURE COMMUNICATIONS (2020)
A novel mouse model of glucagon-like peptide-1 receptor expression: A look at the brain
Devon L. Graham et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2020)
Chronic alcohol disrupts hypothalamic responses to stress by modifying CRF and NMDA receptor function
Vincent N. Marty et al.
NEUROPHARMACOLOGY (2020)
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
Frederic W. Hopf
NEUROPHARMACOLOGY (2020)
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
Daniel Vallof et al.
TRANSLATIONAL PSYCHIATRY (2020)
Semaglutide lowers body weight in rodents via distributed neural pathways
Sanaz Gabery et al.
JCI INSIGHT (2020)
Fibroblast growth factor 21: an endocrine inhibitor of sugar and alcohol appetite
Stephanie von Holstein-Rathlou et al.
JOURNAL OF PHYSIOLOGY-LONDON (2019)
Downregulation of M-channels in lateral habenula mediates hyperalgesia during alcohol withdrawal in rats
Seungwoo Kang et al.
SCIENTIFIC REPORTS (2019)
Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies
Mehdi Farokhnia et al.
CURRENT OPINION IN PSYCHIATRY (2019)
Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents
Daniel Vallof et al.
NEUROPHARMACOLOGY (2019)
Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
Mehdi Farokhnia et al.
PHYSIOLOGY & BEHAVIOR (2019)
Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents
Daniel Vallof et al.
PSYCHONEUROENDOCRINOLOGY (2019)
The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Advances in the science and treatment of alcohol use disorder
K. Witkiewitz et al.
SCIENCE ADVANCES (2019)
Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food
Marie K. Holt et al.
DIABETES (2019)
Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
Annika Billefeld Bornebusch et al.
ENEURO (2019)
YH18968, a Novel 1,2,4-Triazolone G-Protein Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes Mellitus
Taedong Han et al.
BIOMOLECULES & THERAPEUTICS (2018)
Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist
Sylvie Hall et al.
CLINICAL PHARMACOKINETICS (2018)
GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence
Elisabet Jerlhag
NEUROPHARMACOLOGY (2018)
Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study
Yasuo Terauchi et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats
Koji Matsumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Therapeutic application of GPR119 ligands in metabolic disorders
Jin Won Yang et al.
DIABETES OBESITY & METABOLISM (2018)
Disruption of Glucagon-Like Peptide 1 Signaling in Sim1 Neurons Reduces Physiological and Behavioral Reactivity to Acute and Chronic Stress
Sriparna Ghosal et al.
JOURNAL OF NEUROSCIENCE (2017)
APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice
Umakant Ashok Bahirat et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Activation of murine pre-proglucagon-producing neurons reduces food intake and body weight
Ronald P. Gaykema et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
GLP-1 acts on habenular avoidance circuits to control nicotine intake
Luis M. Tuesta et al.
NATURE NEUROSCIENCE (2017)
Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-like Peptide-1 in the Paraventricular Hypothalamus
Ji Liu et al.
NEURON (2017)
Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core
Samantha M. Fortin et al.
PHYSIOLOGY & BEHAVIOR (2017)
Neuropeptide Y in Alcohol Addiction and Affective Disorders
Annika Thorsell et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase
A. A. Spasov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
YH18421, a novel GPR119 agonist exerts sustained glucose lowering and weight loss in diabetic mouse model
Yoo Hoi Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
Daniel Vallof et al.
ADDICTION BIOLOGY (2016)
Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor
H. A. Hassing et al.
BIOFACTORS (2016)
A Functional Switch in Tonic GABA Currents Alters the Output of Central Amygdala Corticotropin Releasing Factor Receptor-1 Neurons Following Chronic Ethanol Exposure
Melissa A. Herman et al.
JOURNAL OF NEUROSCIENCE (2016)
Pharmacotherapy for Substance Use Disorders
Jared Wilson Klein
MEDICAL CLINICS OF NORTH AMERICA (2016)
Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors
Sunil Sirohi et al.
PHYSIOLOGY & BEHAVIOR (2016)
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans
Mette J. Mandoe et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Sustained wash-resistant receptor activation responses of GPR119 agonists
J. Daniel Hothersall et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
The dark side of emotion: The addiction perspective
George F. Koob
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel
Christoph Kapitza et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Jesper Lau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior
Anne E. Harasta et al.
NEUROPSYCHOPHARMACOLOGY (2015)
The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice
Gunnar Sorensen et al.
PHYSIOLOGY & BEHAVIOR (2015)
The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
P. Suchankova et al.
TRANSLATIONAL PSYCHIATRY (2015)
Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
Simon C. Cork et al.
MOLECULAR METABOLISM (2015)
Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse
Sebastien Carnicella et al.
ALCOHOL (2014)
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Anna Secher et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Selective modulation of GABAergic tonic current by dopamine in the nucleus accumbens of alcohol-dependent rats
Jing Liang et al.
JOURNAL OF NEUROPHYSIOLOGY (2014)
Plasticity of GABAA receptor-mediated neurotransmission in the nucleus accumbens of alcohol-dependent rats
Jing Liang et al.
JOURNAL OF NEUROPHYSIOLOGY (2014)
Glucagon-like peptide-1 receptor agonist and basal insulin combination tre atment for the management of type 2 diabetes: a systematic review and meta-analysis
Conrad Eng et al.
LANCET (2014)
The nucleus of the solitary tract and the coordination of respiratory and sympathetic activities
Daniel B. Zoccal et al.
FRONTIERS IN PHYSIOLOGY (2014)
Stress Increases Voluntary Alcohol Intake, but Does not Alter Established Drinking Habits in a Rat Model of Posttraumatic Stress Disorder
Edward M. Meyer et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
Stimulation of Proglucagon Gene Expression by Human GPR119 in Enteroendocrine L-cell Line GLUTag
Oleg G. Chepurny et al.
MOLECULAR ENDOCRINOLOGY (2013)
GLP-1 analog attenuates cocaine reward
D. L. Graham et al.
MOLECULAR PSYCHIATRY (2013)
Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward
Rozita H. Shirazi et al.
PLOS ONE (2013)
The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
Emil Egecioglu et al.
PLOS ONE (2013)
The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
Emil Egecioglu et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile
Graeme Semple et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways
H. Lan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery
Bruce J. Melancon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide
Scott E. Kanoski et al.
NEUROPHARMACOLOGY (2012)
Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats
Andrea Cippitelli et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Long-lasting alterations in membrane properties, K plus currents, and glutamatergic synaptic currents of nucleus accurnbens medium spiny neurons in a rat model of alcohol dependence
Vincent N. Marty et al.
FRONTIERS IN NEUROSCIENCE (2012)
Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake
Naomi J. McKay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control
Graeme Semple et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects
L. B. Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4
Scott E. Kanoski et al.
ENDOCRINOLOGY (2011)
2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans
Katrine B. Hansen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
PREPROGLUCAGON NEURONS PROJECT WIDELY TO AUTONOMIC CONTROL AREAS IN THE MOUSE BRAIN
I. J. Llewellyn-Smith et al.
NEUROSCIENCE (2011)
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice
Shigeru Yoshida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Corticotropin Releasing Factor-Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol Dependence
Marisa Roberto et al.
BIOLOGICAL PSYCHIATRY (2010)
Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
Cassandra Koole et al.
MOLECULAR PHARMACOLOGY (2010)
Role of the glucagon-like-peptide-1 receptor in the control of energy balance
Matthew R. Hayes et al.
PHYSIOLOGY & BEHAVIOR (2010)
Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats
Ali Keshavarzian et al.
JOURNAL OF HEPATOLOGY (2009)
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
John B. Buse et al.
LANCET (2009)
Alcohol and Global Health 1 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Juergen Rehm et al.
LANCET (2009)
Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats
Jeffrey A. Simms et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake
Darleen A. Sandoval et al.
DIABETES (2008)
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release
Zhi-Liang Chu et al.
ENDOCRINOLOGY (2008)
Dual modulation of synaptic transmission in the nucleus tractus solitarius by prostaglandin E2 synthesized downstream of IL-1β
Vincent Marty et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119
Graeme Semple et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement
Nora D. Volkow et al.
JOURNAL OF NEUROSCIENCE (2007)
A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release
Zhi-Liang Chu et al.
ENDOCRINOLOGY (2007)
Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate
Harvey J. Motulsky et al.
BMC BIOINFORMATICS (2006)
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
HA Overton et al.
CELL METABOLISM (2006)
Glucagon and glucagon-like peptide receptors as drug targets
J. L. Estall et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor
T Soga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus
OG Kolterman et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2005)
Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives
R Fredriksson et al.
FEBS LETTERS (2003)
Entry of exendin-4 into brain is rapid but may be limited at high doses
AJ Kastin et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
H Agerso et al.
DIABETOLOGIA (2002)
Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats
PJ Larsen et al.
DIABETES (2001)
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity
A Flint et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Share Paper
